Greater access to medicines by emerging middle class, together with stronger economic prospects in developed nations, is expected to bring total spending on medicines to $1 trillion threshold in 2014 and to $1.2 trillion by 2017, the IMS Institute for Healthcare Informatics reveal. While global drug
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp